News and blogs
351 results found.
New life-changing myeloma drug given positive recommendation for fourth-line use on the NHS for those ‘exhausting’ options
The drug teclistamab (Tecvayli), has been recommended by NICE to treat myeloma, a form of blood cancer, in England and Wales.
10th Oct 2024
Why at Blood Cancer UK we think the new investment towards improving cancer detection from the government is promising
The government has announced a number of new partnerships backed by public and private sector investment to tackle cancer and other life-threatening diseases with faster diagnoses and better treatments, deploying innovative technologies and approaches.
7th Oct 2024
Dr Jewel Cobb – cancer researcher and champion of equality
Dr Jewel Plummer Cobb was an African American cell biologist and physiologist who contributed to pioneering research into cancer treatment.
27th Sep 2024
A step forward for people with blood cancer
The drug quizartinib is now available for people with this specific form of blood cancer on the NHS in England.
24th Sep 2024
World Cancer Research Day: our new research projects
We are funding eight new research projects we are funding taking our total number of research projects to 87 across the UK.
24th Sep 2024
Mpox (monkeypox) and blood cancer
Find out about mpox, how it spreads, signs and symptoms, cases in the UK, and what it means for people with blood cancer.
10th Sep 2024
Our Blood Cancer Action Plan to tackle blood cancer survival in the UK
Blood Cancer UK releases its comprehensive Action Plan "Taking blood cancer out of the shadows: A plan to increase survival in the UK"
4th Sep 2024
Wales lags behind England in blood cancer survival
Our press release on our Blood Cancer Action Plan reveals how Wales is lagging behind England when it comes to blood cancer survival. Our landmark report is available to download in English and Welsh.
4th Sep 2024
Interferon supplies for people with MPNs (Pegasys)
Find out what Blood Cancer UK is doing to solve the UK shortage of pegylated interferon alfa 2a (Pegasys), and what you can do if you take Pegasys to treat an MPN.
3rd Sep 2024
Ellie's blood cancer story
Ellie lived with acute myeloid leukaemia (AML). Her family are encouraging people to donate towards life-saving research.
12th Aug 2024
Take at home tablet approved for blood cancer on NHS England
Zanubrutinib, is now available on the NHS in England for those with a type of blood cancer called marginal zone lymphoma.,
1st Aug 2024
Drug, dasatinib approved for use on the NHS in Scotland
Dasatinib, is now approved for the treatment of adults with a form of leukaemia - Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL) - on the NHS in Scotland.
25th Jul 2024
New class of drug approved for myeloma in England and Wales
The very first bispecific drug for myeloma, elranatamab has been approved for restricted use in England and Wales as a fourth-line treatment.
27th Jun 2024
New blood test for myeloma being researched at Birmingham
Two doctors at the University of Birmingham are developing a new technique to help diagnose and monitor people with the blood cancer, non-measurable myeloma.
17th Jun 2024
Scotland approves two new blood cancer drugs
Two new drugs for the blood cancer, diffuse large B-cell lymphoma DLBCL have been made available for use on the NHS in Scotland as a third-line treatment.
10th Jun 2024
Blood cancer treatment for a form of acute myeloid leukaemia approved for use on NHS
New blood cancer treatment for acute myeloid leukaemia (AML) with IDH1 mutation. The National Institute for Health and Care Excellence (NICE) approved Ivosidenib (Tibsovo) with azacitidine has made it available to those in England and Wales.
24th May 2024
What's the latest evidence regarding COVID-19 vaccines and blood cancer?
Lots of information continues to circulate about COVID-19 and vaccinations for immunocompromised people. Blood Cancer UK’s Healthcare Professional Advisory Panel (HPAP), made up of specialists from across the UK working in haemato-oncology and related professional fields, has released the statement below to help you understand the latest evidence.
15th May 2024
One year later – are we still on track?
Back in 2022, Blood Cancer UK created a new five-year strategy. We made a commitment back then to shape that strategy alongside the Blood Cancer UK community, and to give regular updates. We're now at the end of year one, so it’s the perfect time to stop, reflect and consider whether we're on track.
13th May 2024
Prime Minister recognises blood cancer fundraiser
James Badger, from Harrogate who is raising £300,000 for Blood Cancer UK after his wife passed away from leukaemia has received Prime Minister Rishi Sunak’s Points of Light award.
8th May 2024
Snowman author leaves gift to Blood Cancer UK
Blood Cancer UK are one of three charities left a gift in the Will of the author and illustrator Raymond Briggs, CBE.
1st May 2024